Up a level |
Beale, S ORCID: 0000-0003-0164-103X, Mahon, J, Nevitt, S ORCID: 0000-0001-9988-2709, Boland, A, Greenhalgh, J ORCID: 0000-0003-4812-1904, Richardson, M ORCID: 0000-0002-7097-8704, Kotas, E, Mcentee, J and Green, John
(2017)
Atezolizumab for the treatment of people with locally advanced or metastatic non-small lung cancer whose disease has progressed after chemotherapy.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2017)
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after platinum-based chemotherapy.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Cetuximab for the treatment of squamous cell carcinoma in the head and neck.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904, Stainthorpe, S, Richardson, M ORCID: 0000-0002-7097-8704, Duarte, R, Boland, A ORCID: 0000-0002-5435-8644, Kotas, E, Mcentee, J and Green, John
(2017)
Crizotinib for treating ROS1positive advanced non-small cell lung cancer.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Eribulin for locally advanced or metastatic breast cancer.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Everolimus in combination with an aromatase inhibitor for the treatment of advanced or metastatic HER2 negative, oestrogen receptor positive breast cancer after prior endocrine therapy.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Ex vivo expanded autologous human corneal epithelial cells for treating moderate to severe limbal stem cell deficiency due to ocular burns.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2017)
Nab-paclitaxel with gemcitabine for 1st line metastatic pancreatic adenocarcinoma.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Nanoliposomal irinotecan for treating pancreatic cancer after prior treatment with gemcitabine.
[Report]
Hounsome, J ORCID: 0000-0002-2026-3778, Greenhalgh, J ORCID: 0000-0003-4812-1904, Schofield-Robinson, OJ, Lewis, SR, Cook, TM and Smith, AF
(2018)
Nitrous oxide-based vs. nitrous oxide-free general anaesthesia and accidental awareness in surgical patients: an abridged Cochrane systematic review.
ANAESTHESIA, 73 (3).
pp. 365-374.
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Nivolumab for previously treated locally advanced or metastatic non-small-cell lung cancer.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Nivolumab for treating metastatic, non-squamous, non-small-cell lung cancer after chemotherapy.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904, Aslam, RW, Mahon, J, Krishan, A, Boland, A ORCID: 0000-0002-5435-8644, Beale, S ORCID: 0000-0003-0164-103X, Kotas, E, Banks, L and Green, John
(2016)
Osimertinib for treating locally advanced or metastatic EGFR and T790M mutation-positive non-small cell lung cancer.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904, Mahon, J, Boland, A ORCID: 0000-0002-5435-8644, Beale, S ORCID: 0000-0003-0164-103X, Krishan, A, Abdulla, A, Aslam, R, Kotas, E, Banks, L and Green, John
(2016)
Pembrolizumab for untreated PD-L1 positive metastatic non-small cell lung cancer.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2016)
Pemetrexed maintenance treatment following induction therapy with pemetrexed & cisplatin for non-squamous NSLC.
[Report]
Greenhalgh, J ORCID: 0000-0003-4812-1904
(2017)
Sorafenib and lenvatinib for treating advanced or metastatic thyroid cancer.
[Report]
Bromley, R, Weston, Jennifer, Adab, N, Greenhalgh, J ORCID: 0000-0003-4812-1904, Sanniti, Anna, McKay, AJ ORCID: 0000-0003-1312-8911, Tudur Smith, C ORCID: 0000-0003-3051-1445 and Marson, AG ORCID: 0000-0002-6861-8806
(2014)
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child (Review).
Cochrane Database of Systematic Reviews, 2014 (10).
CD010236-.
Hounsome, J ORCID: 0000-0002-2026-3778, Lee, A, Greenhalgh, J ORCID: 0000-0003-4812-1904, Lewis, SR, Schofield-Robinson, OJ, Coldwell, CH and Smith, AF
(2017)
A systematic review of information format and timing before scheduled adult surgery for peri-operative anxiety.
ANAESTHESIA, 72 (10).
pp. 1265-1272.